These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6630523)

  • 21. [Role of sympathetic nerve activity and arterial endothelial function in pathogenesis of hypertension in patients with obstructive sleep apnea-hypopnea syndrome].
    Zhang J; Chen BY; Han JY; Cao J; Guo MN; Wang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):437-41. PubMed ID: 17673017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the existence of functional beta-adrenoceptors on vascular sympathetic nerve endings in the human forearm.
    Chang PC; Grossman E; Kopin IJ; Goldstein DS
    J Hypertens; 1994 Jun; 12(6):681-90. PubMed ID: 7963493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The sympathetic nervous system in the pathogenesis of hypertension.
    Rahn KH; Barenbrock M; Hausberg M
    J Hypertens Suppl; 1999 Aug; 17(3):S11-4. PubMed ID: 10489093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension.
    Cheung BM; Brown MJ
    J Hypertens; 1994 Apr; 12(4):449-54. PubMed ID: 8064169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes of plasma L-arginine levels in spontaneously hypertensive rats under induced hypotension.
    Prados P; Matsunaga H; Mori T; Santa T; Fukushima T; Homma H; Kasai C; Imai K
    Biomed Chromatogr; 1999 Feb; 13(1):27-32. PubMed ID: 10191940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of norepinephrine uptake blockers on norepinephrine kinetics.
    Esler M; Jackman G; Leonard P; Skews H; Bobik A; Korner P
    Clin Pharmacol Ther; 1981 Jan; 29(1):12-20. PubMed ID: 7460470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of desipramine on norepinephrine metabolism in humans: interaction with aging.
    Stromberg JS; Linares OA; Supiano MA; Smith MJ; Foster AH; Halter JB
    Am J Physiol; 1991 Dec; 261(6 Pt 2):R1484-90. PubMed ID: 1750571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the neuronal removal of circulating epinephrine and norepinephrine.
    Eisenhofer G; Esler MD; Cox HS; Meredith IT; Jennings GL; Brush JE; Goldstein DS
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1710-20. PubMed ID: 2347902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans.
    Willemsen JJ; Ross HA; Jacobs MC; Lenders JW; Thien T; Swinkels LM; Benraad TJ
    Clin Chem; 1995 Oct; 41(10):1455-60. PubMed ID: 7586517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of noradrenaline uptake, spillover to plasma and plasma concentration in patients with essential hypertension.
    Esler M; Jackman G; Leonard P; Bobik A; Skews H; Jennings G; Kelleher D; Korner P
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():311s-313s. PubMed ID: 7449275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma norepinephrine and dihydroxyphenylglycol in essential hypertension.
    Ludwig J; Gerlich M; Halbrügge T; Graefe KH
    Hypertension; 1991 Apr; 17(4):546-52. PubMed ID: 2013481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different desipramine-sensitive pulmonary removals of plasma epinephrine and norepinephrine in dogs.
    Eisenhofer G; Smolich JJ; Esler MD
    Am J Physiol; 1992 Mar; 262(3 Pt 1):L360-5. PubMed ID: 1550259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo measurement of neuronal uptake of norepinephrine in the human heart.
    Goldstein DS; Brush JE; Eisenhofer G; Stull R; Esler M
    Circulation; 1988 Jul; 78(1):41-8. PubMed ID: 3383409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of D, L-3H-norepinephrine in essential hypertension.
    Gitlow S; Dziedzic S; Dziedzic L; Roubein I
    Clin Exp Hypertens (1978); 1981; 3(5):897-918. PubMed ID: 7026196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased norepinephrine spillover into the jugular veins in essential hypertension.
    Ferrier C; Esler MD; Eisenhofer G; Wallin BG; Horne M; Cox HS; Lambert G; Jennings GL
    Hypertension; 1992 Jan; 19(1):62-9. PubMed ID: 1730441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of sympathetic activity in essential hypertension.
    Brown MJ; Lhoste FJ; Zamboulis C; Ind PW; Jenner DA; Dollery CT
    Clin Pharmacol Ther; 1982 Jan; 31(1):16-22. PubMed ID: 7053299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical aspects on presynaptic noradrenaline metabolism.
    Ludwig J; Halbrügge T; Graefe KH
    J Neural Transm Suppl; 1991; 34():69-75. PubMed ID: 1817166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tritium excretion of normotensive and hypertensive subjects after administration of tritiated norepinephrine.
    Gitlow SE; Mendlowitz M; Bertani LM; Wilk EK; Glabman S
    J Lab Clin Med; 1969 Jan; 73(1):129-34. PubMed ID: 5762157
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy.
    Brush JE; Eisenhofer G; Garty M; Stull R; Maron BJ; Cannon RO; Panza JA; Epstein SE; Goldstein DS
    Circulation; 1989 Apr; 79(4):836-44. PubMed ID: 2924414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.